2009
DOI: 10.1016/j.diagmicrobio.2009.03.013
|View full text |Cite
|
Sign up to set email alerts
|

The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2009
2009
2016
2016

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 8 publications
0
11
0
Order By: Relevance
“…This study is limited by its retrospective design, but this is compensated to a great extent by the large size of the study material in comparison with the previous studies of these markers in the diagnosis of LNB (12)(13)(14)(15)(16)(22)(23). The specificity of the assays may have been overestimated because only patients suspected of having LNB on clinical grounds were included in the evaluation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This study is limited by its retrospective design, but this is compensated to a great extent by the large size of the study material in comparison with the previous studies of these markers in the diagnosis of LNB (12)(13)(14)(15)(16)(22)(23). The specificity of the assays may have been overestimated because only patients suspected of having LNB on clinical grounds were included in the evaluation.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, there is a need for additional markers of ongoing LNB. In recent years, the B-lymphocyte attracting chemokine CXCL13 has been proposed as an early CSF marker for LNB (12)(13)(14), and the commercial C6 antibody test has also been evaluated as a marker for LNB in CSF, although with inconsistent results (15)(16).…”
Section: Lyme Borreliosis (Lb) Is the Most Common Tick-borne Infectiomentioning
confidence: 99%
“…Another study used diluted and undiluted CSF with LI cut‐offs of 0.5 and 1 [16]. Retrospectively, 31 tentative cases of LNB were identified by evidence for intrathecal antibody production obtained by western blot.…”
Section: Discussionmentioning
confidence: 99%
“…The commercially available C6‐peptide ELISA has been validated only for serum samples. Data on the performance of the C6‐peptide ELISA performed on CSF for the diagnosis of LNB are limited and conflicting [14–16]. The aim of this study was to determine whether a C6‐peptide‐based ELISA can be used on CSF samples to diagnose early and late LNB patients, using a large cohort of well‐defined patients and controls.…”
Section: Introductionmentioning
confidence: 99%
“…The most observable symptoms include fever, hardness of neck, flu, headache, and headache, inflammation of muscles and joints and fatigue. To nip the evil in bud is the solution of early stage symptoms [20].…”
Section: Disease Sign and Symptomsmentioning
confidence: 99%